Clinical Trials Browser

Phase 1/2 × INDUSTRY × galiximab × Clear all

NCT00048555 2013-09-16

Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma

Phase 1/2 Completed

Lymphoma, Non-Hodgkin

NCT00575068 2012-06-08

Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma

Phase 1/2 Completed

Lymphoma, Non-Hodgkin